Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Heparin-induced thrombocytopenia is rare in pregnancy.

Fausett MB, Vogtlander M, Lee RM, Esplin MS, Branch DW, Rodgers GM, Silver RM.

Am J Obstet Gynecol. 2001 Jul;185(1):148-52.

PMID:
11483919
2.

Heparin-induced thrombocytopenia and recurrent thrombosis in pregnancy. A case report.

Meytes D, Ayalon H, Virag I, Weisbort Y, Zakut H.

J Reprod Med. 1986 Oct;31(10):993-6.

PMID:
3783542
3.

Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients.

Hourigan LA, Walters DL, Keck SA, Dec GW.

J Heart Lung Transplant. 2002 Dec;21(12):1283-9.

PMID:
12490273
4.

Allergy to heparin. Special problems set by pregnant women.

Drouet M, Le Pabic F, Le Sellin J, Bonneau JC, Sabbah A.

Allergol Immunopathol (Madr). 1992 Nov-Dec;20(6):225-9. Review.

PMID:
1296463
5.

Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients.

Schmugge M, Risch L, Huber AR, Benn A, Fischer JE.

Pediatrics. 2002 Jan;109(1):E10.

PMID:
11773578
6.

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.

Creekmore FM, Oderda GM, Pendleton RC, Brixner DI.

Pharmacotherapy. 2006 Oct;26(10):1438-45.

PMID:
16999654
7.

Heparin-induced thrombocytopenia in pregnancy. A case report.

Hatjis CG.

J Reprod Med. 1984 May;29(5):337-8.

PMID:
6726704
8.

Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.

Ban-Hoefen M, Francis C.

Thromb Res. 2009 Jun;124(2):189-92. doi: 10.1016/j.thromres.2009.01.006. Epub 2009 Feb 4.

PMID:
19195684
9.

The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study.

Prandoni P, Siragusa S, Girolami B, Fabris F; BELZONI Investigators Group..

Blood. 2005 Nov 1;106(9):3049-54. Epub 2005 Jul 19.

10.

HIV infection increases the risk of heparin-induced thrombocytopenia.

Thompson GR 3rd, Lawrence VA, Crawford GE.

Clin Infect Dis. 2007 Nov 15;45(10):1393-6. Epub 2007 Oct 8.

PMID:
17968841
11.
12.

Arterial and venous complications of heparin-induced thrombocytopenia in burn patients.

Scott JR, Klein MB, Gernsheimer T, Honari S, Gibbons J, Gibran NS.

J Burn Care Res. 2007 Jan-Feb;28(1):71-5.

PMID:
17211203
13.

Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.

Fabris F, Luzzatto G, Soini B, Ramon R, Scandellari R, Randi ML, Girolami A.

J Intern Med. 2002 Aug;252(2):149-54.

16.

Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalaemia.

Monreal M, Lafoz E, Salvador R, Roncales J, Navarro A.

Eur J Clin Pharmacol. 1989;37(4):415-8.

PMID:
2557219
17.

Etiology of thrombocytopenia in all patients treated with heparin products.

Laber DA, Martin ME.

Eur J Haematol. 2005 Aug;75(2):101-5.

PMID:
16000126
18.

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.

Girolami B, Prandoni P, Stefani PM, Tanduo C, Sabbion P, Eichler P, Ramon R, Baggio G, Fabris F, Girolami A.

Blood. 2003 Apr 15;101(8):2955-9. Epub 2002 Dec 12.

19.

A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparin.

Gerdsen F, Luxembourg B, Langer F, Bauersachs R, Lindhoff-Last E.

Blood Coagul Fibrinolysis. 2008 Sep;19(6):477-81. doi: 10.1097/MBC.0b013e3282f102ea.

PMID:
18685429
20.

Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation.

Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA.

J Interv Cardiol. 2008 Aug;21(4):350-6. doi: 10.1111/j.1540-8183.2008.00363.x. Epub 2008 Jun 4.

PMID:
18537872

Supplemental Content

Support Center